Jump to content

Cytoprotection

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Walidou47 (talk | contribs) at 13:25, 12 March 2020. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Cytoprotection is a process by which chemical compounds provide protection to cells against harmful agents.[1]

Gastric cytoprotectant

A gastric cytoprotectant is any medication that combats ulcers not by reducing gastric acid but by increasing mucosal protection.[2] Examples of gastric cytoprotective agents include prostaglandins which protect the stomach mucosa against injury by increasing gastric mucus secretion. Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit the synthesis of prostaglandins and thereby make the stomach more susceptible to injury.[3] Gastric cytoprotective drugs include carbenoxolone, deglycyrrhizinised liquorice, sucralfate (aluminium hydroxide and sulphated sucrose), misoprostol (a prostaglandin analogue), bismuth chelate (tri-potassium di-citrato bismuthate) and zinc L-carnosine.

References

  1. ^ "MeSH Heading: Cytoprotection". Medical Subject Headings. United States National Library of Medicine.
  2. ^ Tulassay Z, Herszényi L (April 2010). "Gastric mucosal defense and cytoprotection". Best Pract Res Clin Gastroenterol. 24 (2): 99–108. doi:10.1016/j.bpg.2010.02.006. PMID 20227024.
  3. ^ Wallace JL (September 1992). "Prostaglandins, NSAIDs, and cytoprotection". Gastroenterol. Clin. North Am. 21 (3): 631–41. PMID 1516961.
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Cytoprotection&oldid=945203883"